Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/ADROVANCE 70 MG/5.600 UI COMPRIMIDOS

Approved

STANDARD

ADROVANCE 70 MG/5.600 UI COMPRIMIDOS

Organon N.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 12, 2024
Approval ID: 490039ddd1bcffbd
Company: Organon N.V.
Type: Standard

Approval Details

Approval Id: 490039ddd1bcffbd
Drug Cima Aemps Name: ADROVANCE 70 MG/5.600 UI COMPRIMIDOS
Register Number: 06364007IP
Holder Company Name: Organon N.V.
Marketing Company Name: Elam Pharma Labs S.L.
Authorization Date: 2024-07-12
Dosage Form: COMPRIMIDO
Dose: 70 MG/5.600 UI
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Organon N.V.

Active Ingredients

ALENDRONATO SODIO TRIHIDRATO

70 mg

COLECALCIFEROL

5600 UI

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 12, 2024

Approval ID

490039ddd1bcffbd

Type

Standard

Back to CIMA-AEMPS Approvals

ADROVANCE 70 MG/5.600 UI COMPRIMIDOS - CIMA-AEMPS Drug Approval Details